COVID-19

News

Convalescent plasma misses the mark in phase 2 trial

Hopes that antibody-laden plasma taken from recovered COVID-19 patients could lessen the severity of the disease in others have taken a knock.

Views & Analysis

Data hackathon analyses truth behind ‘game-changer’ COVID vaccine

Data hackathon analyses truth behind TB vaccine and COVID-19

Is a century-old vaccine a ‘game-changer’ for COVID-19?

News

Gilead’s remdesivir finally gets US approval

Gilead’s Veklury (remdesivir) has become the first COVID-19 drug approved in the US following a nod from the FDA.

News

Roche to co-develop remdesivir rival in partnership with Ate...

Roche may not be the first company that comes to mind for a COVID-19 treatment, but the Swiss firm is taking a big swing at the market to rival Gilead’s

News

AZ's COVID-19 vaccine trial ready to resume in US - reports

AstraZeneca’s COVID-19 vaccine trial could be ready to resume this week in the US after a seven-week hiatus while the FDA completed its review of a serious illness, according to reports.

Views & Analysis